|
|
Article: US Oncology Extends Tender Offer and Consent Solicitation for Its 9 5/8% Senior Subordinated Notes Due 2012.
- Article from:
- PR Newswire
- Article date:
- August 16, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
US Oncology, Inc. ("US Oncology") announced today that it is extending the tender offer expiration date and consent expiration date for its previously announced cash tender offer and consent solicitation relating to its 9 5/8% Senior Subordinated Notes due 2012. The tender offer and consent solicitation, each of which was to have expired at 5:00 p.m., New York City time, on Friday, Aug. 13, 2004, will each be extended to 9 a.m., New York City time, on Friday, Aug. 20, 2004, unless further extended by US Oncology.
To date, holders of approximately $172,000,000 of the outstanding principal amount of the notes, which represents approximately 98% of the $175 million ...